PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
304.00
+2.00 (0.66%)
Feb 10, 2026, 11:20 AM WIB

IDX:DGNS Balance Sheet

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
3,5174,20910,24528,01144,72016,538
Short-Term Investments
959.59959.591,6962,5436,507-
Cash & Short-Term Investments
4,4765,16911,94130,55351,22716,538
Cash Growth
--56.71%-60.92%-40.36%209.75%1086.91%
Accounts Receivable
48,02141,81038,28042,42241,73050,816
Other Receivables
7,3257,0796,9727,03332,2095,977
Receivables
55,34648,88945,25249,45573,93981,273
Inventory
4,7655,0435,1426,5677,7605,813
Prepaid Expenses
469.11275.79194.89266.08784.9256.19
Other Current Assets
20,41719,23125,27531,53220,1531,473
Total Current Assets
85,47478,60887,805118,373153,864105,154
Property, Plant & Equipment
202,100202,426164,248109,21987,10720,108
Long-Term Investments
12,95112,95112,9518,445--
Other Intangible Assets
1,5621,353720.43681.12--
Long-Term Deferred Tax Assets
815.57815.571,0311,0201,012762.7
Long-Term Deferred Charges
-----6,550
Other Long-Term Assets
2,7363,8694,7192,198--
Total Assets
305,638300,022271,475239,936241,983132,575
Accounts Payable
8,6889,5516,0903,0784,52415,825
Accrued Expenses
4,1784,1163,1781,5563,125140.09
Current Portion of Long-Term Debt
3,241152.08-1,701--
Current Portion of Leases
4,0315,0123,7101,8112,390634.66
Current Income Taxes Payable
352.16255.12268.87674.8316,01312,763
Current Unearned Revenue
3,9201,748651.53893.77--
Other Current Liabilities
266.24772.59545.72777.24576.261,249
Total Current Liabilities
24,67621,60614,44410,49226,62830,612
Long-Term Debt
49,60844,81730,0009,358-677.76
Long-Term Leases
20,87020,40121,004409.042,8881,273
Long-Term Unearned Revenue
7,0557,820----
Pension & Post-Retirement Benefits
1,4931,2922,1561,6863,103708.19
Other Long-Term Liabilities
8,4537,9548,2807,5637,563237.09
Total Liabilities
112,156103,89075,88529,50840,18233,508
Common Stock
31,25031,25031,25031,25031,25025,000
Additional Paid-In Capital
36,70736,70736,70736,70736,70728.98
Retained Earnings
129,615132,265131,518145,173132,50974,205
Comprehensive Income & Other
-4,090-4,090-3,884-2,7021,335-167.65
Shareholders' Equity
193,482196,132195,590210,428201,80099,066
Total Liabilities & Equity
305,638300,022271,475239,936241,983132,575
Total Debt
77,75070,38254,71413,2795,2772,586
Net Cash (Debt)
-73,274-65,213-42,77317,27445,95013,953
Net Cash Growth
----62.41%229.33%-
Net Cash Per Share
-58.62-52.17-34.2213.8237.0413.95
Filing Date Shares Outstanding
1,2501,2501,2501,2501,2501,000
Total Common Shares Outstanding
1,2501,2501,2501,2501,2501,000
Working Capital
60,79857,00273,361107,881127,23674,542
Book Value Per Share
154.79156.91156.47168.34161.4499.07
Tangible Book Value
191,919194,779194,870209,747201,80099,066
Tangible Book Value Per Share
153.54155.82155.90167.80161.4499.07
Land
54,64354,64343,65543,65543,655-
Machinery
47,84446,44744,28539,54831,77118,263
Construction In Progress
95,13388,00153,06118,411311.4-
Leasehold Improvements
27,72127,85726,02623,67214,2011,580
Source: S&P Global Market Intelligence. Standard template. Financial Sources.